Cargando…
Mitf-Mdel, a novel melanocyte/melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for melanoma
BACKGROUND: Melanoma incidence is on the rise and advanced melanoma carries an extremely poor prognosis. Treatment options, including chemotherapy and immunotherapy, are limited and offer low response rates and transient efficacy. Thus, identification of new melanocyte/melanoma antigens that serve a...
Autores principales: | Wang, Yixiang, Radfar, Soroosh, Liu, Suhu, Riker, Adam I, Khong, Hung T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839965/ https://www.ncbi.nlm.nih.gov/pubmed/20163701 http://dx.doi.org/10.1186/1741-7015-8-14 |
Ejemplares similares
-
Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma
por: Wiedemann, Gabriela M, et al.
Publicado: (2018) -
Endolysosomal Cation Channels and MITF in Melanocytes and Melanoma
por: Abrahamian, Carla, et al.
Publicado: (2021) -
The 14-3-3σ gene promoter is methylated in both human melanocytes and melanoma
por: Liu, Suhu, et al.
Publicado: (2009) -
Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression
por: Oh, Taek-In, et al.
Publicado: (2017) -
Hypoxia-inducible factor 1α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells
por: Buscà, Roser, et al.
Publicado: (2005)